• Patients and physicians have a new option to share Quest Diagnostics' diagnostic laboratory data online through a secure electronic health record. For more information, visit Google Health.
• Learn more about how our newest lab is serving physicians and patients in India by visiting: QuestDiagnostics.In.
• Join the challenge to help increase the number of people screened annually for colorectal cancer. Visit www.DoYouHaveTheGuts.com.

• Better health for a better you. Find out how with our laboratory based employee wellness program: Blueprint for Wellness.

Quest Diagnostics Reports Strong Revenue and Earnings Growth in Second Quarter 2008

	-		Total revenues of $1.8 billion, up 12%;
	-		Diluted earnings of $0.83 per share, up 14%;
	-		Cash flow improved to $213 million;
	-		2008 EPS guidance midpoint increased, new range $3.10 to $3.20 per diluted share.
	-		Listen to a replay of the second quarter earnings conference call
	-		Read a transcript of company prepared remarks

Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program

HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker

Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds

Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds